MetroBoston Clinical Partners

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)3 trials
• Psoriasis2 trials

Phase

• Phase 34 trials
• Phase 22 trials

Status

• Active, not recruiting2 trials
• Completed2 trials
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• Alumis Inc2 trials
• Amgen1 trial
• Bluefin Biomedicine, Inc.1 trial
• RAPT Therapeutics, Inc., a member of the GSK plc group of companies1 trial
• Verrica Pharmaceuticals Inc.1 trial

Running trials

• Recruiting

  Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)

  NCT07637734· Phase 3· Verrica Pharmaceuticals Inc.· Source

  Contact: Project Manager

• Active, not recruiting

  A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis

  NCT07105488· Phase 2· Bluefin Biomedicine, Inc.· Source

• Active, not recruiting

  Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis

  NCT06846541· Phase 3· Alumis Inc· Source

Closed trials

• Completed

  A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis

  NCT06586112· Phase 3· Alumis Inc· Source

• Completed

  A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)

  NCT05651711· Phase 3· Amgen· Source

• Terminated

  An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis

  NCT05399368· Phase 2· RAPT Therapeutics, Inc., a member of the GSK plc group of companies· Source